Genotype/Phenotype Analyses for 53 Crohn's Disease Associated Genetic Polymorphisms

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Jung, Camille ^a,b,c   Colombel, Jean Frédéric ^d   Lemann, Marc ^e   Beaugerie, Laurent ^f   Allez, Matthieu ^e   Cosnes, Jacques ^f   Vernier Massouille, Gwenola ^d   Gornet, Jean Marc ^e   Gendre, Jean Pierre ^f   Cezard, Jean Pierre ^c   Ruemmele, Frank M ^a   Turck, Dominique ^d   Merlin, Françoise ^a,b   Zouali, Habib ^g   Libersa, Christian ^h   Dieudé, Philippe ^a   Soufir, Nadem ^a   Thomas, Gilles ^g   Hugot, Jean Pierre ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UNIV LILLE   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g FONDATION JEAN DAUSSET CEPH   (France)

^h University of Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 1; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 23 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; ATG16L1 GENE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DEFB1 GENE; DRUG RESPONSE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IL23R GENE; IRGM GENE; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NOD2 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COHORT STUDIES; CROHN DISEASE; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; MEDICAL RECORDS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 84871894086     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052223     Document Type: Article

References (53)

1. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-11.
2. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-62.
3. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
4. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-3.
5. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596-604.
6. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39: 830-2.
7. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36: 471-5.
8. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36: 476-80.
9. Libioulle C, Louis E, Hansoul S, Sandor C, Farnr F, et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3: e58.
10. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, et al. (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40: 1211-5.
11. Franke A, Hampe J, Rosenstiel P, Becker C, Wagner F, et al. (2007) Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS ONE 2: e691.
12. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, et al. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 41: 71-6.
13. Koslowski MJ, Kubler I, Chamaillard M, Schaeffeler E, Reinisch W, et al. (2009) Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One 4: e4496.
14. Kocsis AK, Lakatos PL, Somogyvari, Fuszek P, Papp J, et al. (2008) Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol 43: 299-307.
15. Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, et al. (2007) An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 16: 3008-16.
16. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743-56.
17. Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, et al. (2009) Association between genetic variants in myosin IXB and Crohn's disease. Inflamm Bowel Dis 15: 1014-21.
18. McGovern DP, Taylor KD, Landers C, Derkowski C, Dutridge D, et al. (2009) MAGI2 genetic variation and inflammatory bowel disease. Inflamm Bowel Dis 15: 75-83.
19. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 42: 1118-25.
20. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, et al. (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40: 1107-12.
21. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, et al. (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40: 713-5.
22. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J, (2006) Predictors of Crohn's disease. Gastroenterology 130: 650-6.
23. Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with Inflammatory Bowel Disease. Am J Hum Genet 70: 845-57.
24. Mascheretti S, Schreiber S, (2005) Genetic testing in Crohn disease: utility in individualizing patient management. Am J Pharmacogenomics 5: 213-22.
25. Henckaerts L, Van Steen K, Verstreken I, Cleyden I, Franke A, et al. (2009) Genetic risk profiling and prediction of disease course in Crohn's disease patients. Clin Gastroenterol Hepatol. 7: 972-980.
26. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170: 2-6.
27. Guedj M, Bourillon A, Combadières C, Rodero M, Dieudé P, et al. (2008) Variants of the MATP/SLAC gene are oprotective for melanoma in the French population. Human Mutat 29: 1154-60.
28. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ, (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121: 255-60.
29. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn W, (2010) The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 105: 289-97.
30. Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, et al. (2011) Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 43: 43-7.
31. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-73.
32. Radford-Smith G, Pandeya N, (2006) Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease-Are we there yet? World J Gastroenterol 12: 7097-103.
33. Prescott NJ, Fisher SA, Franke A, Hampe J, Onnie CM, et al. (2007) A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132: 1665-71.
34. Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, et al. (2006) Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 41: 1421-32.
35. Adler J, Rangwalla SC, Dwamena BA, Higgins PD, (2011) The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis. Am J Gastroenterol 106: 699-712.
36. Fowler EV, Doecke J, Simms LA, Zhao ZZ, Webb PM, et al. (2008) ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity. Am J Gastroenterol 103: 2519-26.
37. Cummings JR, Cooney R, Pathan S, Anderson CA, Barrett JC, et al. (2007) Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene. Inflamm Bowel Dis 13: 941-6.
38. Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, et al. (2007) Association of the T300A non-synonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut 56: 1171-3.
39. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, et al. (2008) Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. Inflamm Bowel Dis 14: 338-46.
40. Latiano A, Palmieri O, Valvano MR, D'Inca R, Cucchiara S, et al. (2008) Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol 14: 4643-51.
41. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, et al. (2007) IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 102: 2754-61.
42. Hancock L, Beckly J, Geremia A, Cooney R, Cummings F, et al. (2008) Clinical and molecular characteristics of isolated colonic Crohn's disease. Inflamm Bowel Dis 14: 1667-77.
43. Latiano A, Palmieri O, Cucchiara S, Castro M, D'Inca R, et al. (2009) Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol 104: 110-6.
44. Duraes C, Machado JC, Portela F, Rodrigues S, Lago P, et al. (2012) Phenotype-genotype profiles in Crohn's Disease predicted by genetic markers in autophagy related genes (GOIA study II). Inflamm Bowel Dis may 9 (epub ahead of print).
45. Waterman M, Xu W, Stempak JM, Milgrom R, Bernstein CN, et al. (2011) Distinct and overlapping genetic loci in Crohn's Disease and Ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis 17: 1936-42.
46. Palomino-Morales RJ; Oliver J, Gomez-Garcia M, Lopez-Nevot MA, Rodrigo L, et al. (2009) Association of the ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun 10: 356-64.
47. Tremelling M, Cummings F, Fisher SA, Mansfiled SA, Gwilliam R, et al. (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132: 1657-64.
48. Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, et al. (2008) ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol 103: 621-7.
49. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, et al. (2007) IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 56: 1173-4.
50. Lappalainen M, Halme L, Turunen U, Saavalainen P, Einarsdottir E, et al. (2008) Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis 14: 1118-24.
51. Marquez A, Mendoza JL, Taxonera C, Diaz-Rubio M, De La Concha EG, et al. (2008) IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis 14: 1192-6.
52. Peyrin-Biroulet L, Bigard MA, Malesci A, Danese S, (2008) Step-up and top-down approaches to the treatment of Crohn's disease: early may already be too late. Gastroenterology 135: 1420-2.
53. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P,et al 2010) The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohn's and Colitis 4: 7-27.